FDA Import Refusal D52-0208233-1/31/1 — Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co. Ltd.
The FDA refused shipment D52-0208233-1/31/1 from Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co. Ltd. (China) on August 10, 2022. The refused product falls under Drugs and Biologics — ANALGESIC, N.E.C.. Cited charge: 118 This firm has 1 other import refusal on record.
Refusal Details
- Date
- August 10, 2022
- Country
- China
- Product Category
- Drugs and Biologics
- Product Code
- 60LAJ99 ANALGESIC, N.E.C.
- Charges
- 118